Berlin, Germany -- (SBWire) -- 07/01/2022 --Research that has been carried out via a collaboration between Canadian and German researchers has found that new drug combinations may be more effective at treating obesity and diabetes than single drugs. They may also be able to replace many of the more invasive options that are often suggested for these conditions, including bariatric surgery. The research has looked at drugs that control incretins, which are metabolic hormones used in the human body to produce and control insulin. As a result of the research, it has become clear that combining the drug not only means that it is likely to be more effective but also that there are fewer side effects for patients to contend with. Some of the patients taking part in the trial achieved up to a 15% weight loss - this is impressive given that in most trials weight loss of just 5% is considered to be meaningful. Further research is recommended to identify why some individuals respond better to the drug than others.

EPM Scientific is a biotech recruiter supporting innovative organisations in finding solutions to some of the biggest challenges of our time, including obesity and diabetes. The firm's expertise is not just as a biotech recruiter, as the team at EPM Scientific also has experience in many other areas of life sciences hiring, including commercial, medical affairs, medical communications, clinical development and clinical operations. Over the years the team has built up a database of more than a million mid-to-senior professionals to connect with businesses in life sciences keen to build a resilient talent pipeline. The firm also has the advantage of being able to use a versatile range of tools to design hiring options for every type of business, from permanent to contract and multi-hire solutions. EPM Scientific is also a biotech recruiter with an exceptional network of connections within organisations, one of the reasons why it has become a go-to for talented individuals looking to take a career-defining next step.

As a biotech recruiter in Europe, EPM Scientific has built up an extensive reach that includes major cities in Germany, such as Berlin and Munich, as well as Frankfurt, Hamburg and Cologne, and beyond. The team in Germany is also part of a global workforce of well over a thousand people that brings a robust international element to its network. Plus, EPM Scientific is also the recruitment partner of choice to hundreds of world-leading companies as part of the Phaidon International group, which operates across 6 countries. As a biotech recruiter, EPM Scientific has been actively focused on ensuring that business-critical talent can be matched with those enterprises where they are likely to make the biggest difference. This is achieved, in part, thanks to the exceptional team, which the firm has invested heavily in. Consultants are trained on an ongoing basis and work with best-in-class recruitment technology and strategies. There are many different roles available via the firm today, including Director [Rare Disease Marketing], Safety Analyst & Programmer and Project Engineer.

The team at EPM Scientific said, "At the heart of every organisation is its people, and in Life Sciences it's no different. We predict in 2022 the demand for talent will not slow down, with particular interest in talent that can take your drug, device or therapeutic application through from conception in Research & Development all the way to Clinical. Sales & Marketing is also another area of growth for us in 2022.

The world has never looked so keenly into Pharma and Life Sciences. As the vaccines have been, and continue to be, rolled out worldwide, talent shortages have also never been more prominent. There are plenty of opportunities for strong talent to making moves across new studies and add another life-changing project to their CV."

To find out more information about Biotech recruiter in Germany visit https://www.epmscientific.de.

For any media inquiries please contact Gary Elliott at Iconic Digital – 020 71000726.

For all other enquiries please contact EPM Scientific DE: +49 30 72 62 11 444.

For more information about EPM Scientific DE services, please go to https://www.epmscientific.de.

About EPM Scientific DE
EPM Scientific DE partners with organisations across the fast-expanding pharmacovigilance sector. The firm's 1000+ employees support growth and development among enterprises where innovation and insight will be crucial to both current and future generations.